Targeted peptide protocols designed to support ovarian reserve, sperm quality, implantation, and hormonal signaling. Evidence-informed, compounded by licensed pharmacies, prescribed through telehealth.
A 15-amino acid peptide derived from a protective gastric protein. Shown in preclinical research to promote angiogenesis and vascular integrity — mechanisms relevant to endometrial receptivity and uterine blood flow. Also studied for its role in modulating nitric oxide pathways and reducing systemic inflammation, both of which affect reproductive outcomes.
Current use in fertility-adjacent protocols focuses on uterine lining support and reducing the inflammatory burden that can interfere with implantation.
A synthetic tetrapeptide (Ala-Glu-Asp-Gly) based on the pineal gland's natural epithalamin. Investigated primarily for its telomerase-activating properties and anti-aging effects. In reproductive medicine, its relevance lies in ovarian aging — telomere shortening is a recognized driver of diminished ovarian reserve and egg quality decline.
Research in older female models suggests Epithalon may partially restore ovarian function and delay age-related fertility decline, though robust human clinical data remains limited.
A naturally occurring neuropeptide that acts as a critical regulator of the hypothalamic-pituitary-gonadal (HPG) axis. Kisspeptin neurons in the hypothalamus drive GnRH pulsatility — the upstream signal for LH and FSH secretion. Without adequate kisspeptin signaling, the entire reproductive hormone cascade is disrupted.
Kisspeptin-10 protocols are being studied in clinical trials for triggering ovulation in IVF, treating hypothalamic amenorrhea, and restoring HPG axis function in women with functional infertility related to stress, exercise, or energy deficit.
A synthetic analog of alpha-MSH that acts on melanocortin receptors in the central nervous system. Unlike direct hormonal interventions, PT-141 works through neurological pathways rather than vascular mechanisms. FDA-approved as Vyleesi for female hypoactive sexual desire disorder (HSDD).
In a broader reproductive health context, restoring sexual function is a clinically meaningful outcome for patients navigating fertility stress, hormonal dysregulation, or post-treatment recovery where libido is compromised.
Share your goals, health history, and current medications through our secure intake form.
A board-certified provider reviews your history and conducts a telehealth consultation. Labs may be ordered.
If appropriate, a peptide protocol is prescribed — compounded at a licensed cGMP pharmacy to your specifications.
Follow-up consultations, lab reviews, and protocol adjustments. You're not on your own after the package arrives.
Submit your intake and a licensed provider will reach out to schedule your consultation.
Request Consultation